Application of immune-related gene in kit and system for prognosis of colorectal cancer
A colorectal cancer, immune-related technology, applied in ICT adaptation, biostatistics, biochemical equipment and methods, etc. Scale verification and other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Discovery of prognostic immune-related genes in colorectal cancer
[0020] The data set numbered GSE39582 in the public high-throughput GEO database is used as the development data set, and the measurement platform is the microarray platform of Affymetrix Company, which contains 566 samples of colorectal cancer patients, hereinafter referred to as the CIT microarray data set. Among them, there were 557 patients with complete clinical prognosis information, and 309 cases of early colorectal cancer. The immune-related genes were obtained from the ImmPort database, with a total of 1811 genes and 17 categories, of which 1264 immune-related genes were available in the GSE39582 dataset.
[0021] Construction of immune-related genes for prognosis prediction of colorectal cancer
[0022] According to the patient's prognosis information, using the LASSO Cox model, the 1264 immune-related genes were reduced to 23 genes, such as figure 1 In addition, see Table 1 for the list...
Embodiment 2
[0028] Example 2 Prediction of colorectal cancer prognosis using this model
[0029]Tested on a training cohort (CIT / GSE39582), two validation cohorts (TCGA CRC and Meta-validation), a total of 1587 patient samples. As shown in the figure, the test effect on the CIT microarray data set (HR=2.55, 95%CI=1.88-3.45, P<0.001), on the colorectal cancer patients in the TCGA CRC (validation-1) data set The test effect (HR=1.64, 95%CI=1.10-2.44, P=0.001), the test effect (HR =2.61, 95%CI=1.71-3.98, P<0.001).
[0030] As shown in Table 2, the present invention also compares the constructed immune signature gene model (IRGS) with the Oncotype DX algorithm model proposed internationally at present; the results found that in the CIT / GSE39582 and TCGA CRC cohorts, the prediction index of IRGS (C- index) are better than the Oncotype DX algorithm, and the prediction index in the Meta-validation verification data set is equal to that of the Oncotype DX algorithm.
[0031] Table 2
[0032...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com